Evaluation of the Management of Urolithiasis with Clinical Study
Management of Urolithiasis
Background: Urolithiasis encompasses both renal and ureteric stones. It is estimated that up to 5% of the world population is affected by this disease and the lifetime risk of getting urinary stone is 8-15%. The aim of this study is to look for epidemiological patterns in the disease distribution, understand the causative factors of the disease and assess the existing surgical modalities of treatment of this disease. Subjects and Methods: In the present study 68 cases of Urolithiasis fulfilling the study parameters were admitted and subsequently operated in Medical College and Research Hospital. Results: 65% of the patients were between age group 18-40. The most common site of urinary calculus was lower 1/3ureter followed by lower pole kidney. Diet, fluid intake, diabetes and obesity were significant predisposing factors for urolithiasis. PCNL was the treatment of choice for renal calculus while ECSWL was treatment of choice in upper ureteric calculi and ureteroscopy for lower ureteric calculi. Conclusion: For renal calculi, PCNL is the best treatment modality as of now, but it is associated with greater post-operative morbidity. For stone less than 1cm size, ECSWL is a good alternative to PCNL, but has poor clearance rate and thus greater need for auxiliary procedure. For ureteric calculi, both ECSWL and ureteroscopy have given good results but ECSWL is better tolerated by the patients.
Nicolle LE. A practical guide to antimicrobial manage- ment of complicated urinary tract infection. Drugs Aging. 2001;18:243–54.
Prstojevic J, Junuzovic D, Hasanbegovic M, Lepara Z, Selimovic M. Characteristics of Calculi in the Urinary Tract. Materia Socio Medica. 2014;26:297–297. Available from: https://dx.doi.org/10.5455/msm.2014.26.297-302.
Junuzovic D, Prstojevic J, Hasanbegovic M, Lepara Z. Evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL): Efficacy in Treatment of Urinary System Stones. Acta Informatica Medica. 2014;22(5):309–309. Available from: https://dx.doi.org/10.5455/aim.2014.22.309-314.
Wang RC. Managing urolithiasis. Ann Emerg Med. 2016;67:449–54.
Fwu CW, Eggers PW, Kimmel PL, Kusek JW, Kirkali Z. Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States. Kidney Int. 2013;83(3):479–486. Available from: https://dx.doi.org/10.1038/ki.2012.419.
Arya MC, Hariyawat BS, Vasudeo V, Jadaon AS, Gandhi A, Singhal A. PCNL in Staghorn Calculi: Our Experience. Asian J Med Res. 2019;8(3):SG01–SG03.
Sabharwal S, , and NJ. Efficacy of Alpha-1 Adrenergic Block- ers in the Management of Benign Prostatic Hyperplasia. Asian Journal of Medical Research. 2019;8(2):SG01–SG05. Avail- able from: https://dx.doi.org/10.21276/ajmr.2019.8.2.sg1.
Helfand B, Mouli S, Dedhia R, McVary KT. Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia With Open Prostatectomy: Results of a Contemporary Series. J Urol. 2006;176(6):2557–2561. Available from: https://dx.doi.org/10.1016/j.juro.2006.07.143.
Stuurman RE, Al-Qahtani SM, Cornu JN, Traxer O. Ante- grade Percutaneous Flexible Endoscopic Approach for the Management of Urinary Diversion-Associated Complications. J Endourol. 2013;27(11):1330–1334. Available from: https://dx.doi.org/10.1089/end.2012.0371.
Dodd GD, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, et al. Minimally Invasive Treatment of Malignant Hepatic Tumors: At the Threshold of a Major Breakthrough. Radiographics. 2000;20(1):9–27. Available from: https://dx.doi.org/10.1148/radiographics.20.1.g00ja019.
Ahangar S, Durrani AM, Qadri SJ, Patloo AM, Ganaie RG, Khan M. Laparoscopic trans-peritoneal pyelolithotomy in a pelvic kidney. Saudi J Kidney Dis Transplant. 2012;23:1254– 58.
López M, Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatr Nephrol. 2010;25(1):49–59. Available from: https://dx.doi.org/10.1007/s00467-008-0960-5.
Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral Stones Clinical Guidelines Panel Summary Report on the Management of Ureteral Calculi. J Urol. 1997;158(5):1915–1921. Available from: https://dx.doi.org/10.1016/s0022-5347(01)64173-9.
Copyright (c) 2020 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.